Differential reprogramming of breast cancer subtypes in 3D cultures and implications for sensitivity to targeted

Esmee Koedoot1, Liesanne Wolters2, Marcel Smid3

  • 1Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research (LACDR), Leiden University, 2300 RA, Leiden, The Netherlands. e.koedoot@lacdr.leidenuniv.nl.

Scientific Reports
|April 1, 2021
PubMed

Related Concept Videos